Lynch joined MedMen as interim CEO and chief restructuring officer in March 2020, a few months after Adam Bierman stepped down as chief executive at the company he launched a decade earlier.
Restructuring the cannabis operator will be a tall order. The company has struggled to retain senior executives and continues to chase profitability.
For its fiscal year that ended June 27, 2020, MedMen reported a loss of $526.5 million on revenue of $157.1 million. In the nine-month period that ended March 27, 2021, MedMen reported a combined loss of $111.4 million.
The company said that a $9.7 million loss in its third quarter was its “best net loss in the company’s history.”
Lynch was unavailable for comment.
MedMen, which became the first U.S.-based cannabis company to go public on the Canadian Securities Exchange in 2018, has seen its share of challenges.
The company has laid off a large chunk of its workforce. It canceled a $682 million strategic acquisition of PharmaCann in October 2019 to focus on its retail operations in California and other states. And it has had a revolving door for chief financial officers.
MedMen's highest profile CFO was Michael Kramer, who helped launch Apple Inc.’s retail stores. His mission was to right the ship at one of the fledgling industry’s most ambitious companies and to prevent it from burning cash as it pursued an aggressive expansion.
The expansion has since been slowed.
Lynch is a partner and senior managing director at SierraConstellation Partners, a downtown-based interim management and advisory firm. He previously served as chairman and CEO of Hollywood-based lingerie retailer Frederick’s of Hollywood Group Inc., an arm of New York-based Authentic Brands Group LLC.
Lynch also served as interim CEO of Conshohocken, Pa.-based wedding dress and gown company David’s Bridal, which he led out of bankruptcy.
With Frederick’s, Lynch led an out-of-court financial and operational restructuring which culminated in a sale to hedge fund investor Phil Falcone’s HRG Group in 2014.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Struggling MedMen Seeks Restructuring, Turnaround
- MedMen Revenue Falls 23%
- MedMen Secures $26 Million in Loans
- MedMen Sells More Assets
- MedMen to Lay Off Nearly 200, Sets Restructuring Plan
- MedMen Restructuring Brings $37 Million in Savings
- MedMen CEO Bierman Steps Down
- MedMen Enterprises Names Interim CFO